Global Cystoscope Market - Forecasts from 2018 to 2023

September 2018 | 90 pages | ID: GBC1F2D3C0BEN
Knowledge Sourcing Intelligence LLP

Abstracts

The global cystoscope market is projected to grow at a CAGR of 6.30% during the forecast period of 2017-2023. Cystoscope is a thin, telescope-like tube with a light and tiny camera attached instrument used to perform cystoscopy, also known as cystourethroscopy that allows physician to examine and treat the lower urinary tract (urethra, prostate, bladder neck, and bladder). The cystoscope is inserted into bladder through urethra for the evaluation, treatment or diagnoses of the conditions such as Bladder cancer, haematuria, frequent urinary tract infections (UTIs), Urinary blockage, Urinary stones etc. making cystoscopy procedures one of the most commonly performed procedures in the urology office settings.
Rising incidences of the urinary tract diseases to boost the market
The growth in the global cystoscope market may be attributed to the rising prevalence of the urinary tract diseases globally. As per the data by National Kidney foundation, there are approximately 10 million doctor visit for urinary tract infections in the US. Similar rising incidences of other diseases such as prostate cancer, stones, bladder cancer etc. will also boost the market during the given time frame. As per Cancer research UK, prostate cancer is the most common cancer in men with around 47,700 new prostate cancer cases in the UK every year. However, complications such as infections, bleeding and swollen urethra that may arise during cystoscopy procedure might restrain the growth of the market during the forecast period.
North America to hold significant share
Geographically, North America is expected to hold a significant share owing to the well-established healthcare infrastructure in the region. Quick adoption and implementation of the latest technologies along with the favorable reimbursement policies will also bolster the market in the region during the forecast period. Asia Pacific owing to the huge patient base coupled with the improving healthcare infrastructure is estimated to show the robust growth through to 2023.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global proteomics market.

Major industry players profiled as part of the report are Henke-Sass Wolf, Olympus Corporation, Stryker and NeoScope Inc. among others.

Segmentation

• By Type
• Rigid Cystoscope
• Flexible Cystoscope
• By Applications
• Urology
• Gynaecology
• By End-User
• Hospitals & Clinics
• Ambulatory Surgical Centres
• By Geography
• North America
• United States
• Canada
• Others
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Others
• Middle East and Africa
• UAE
• Saudi Arabia
• Israel
• Others
• Asia Pacific
• China
• India
• Australia
• South Korea
• Others

Contents

1. INTRODUCTION

1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources
2.3. Validation

3. KEY FINDINGS OF THE STUDY

4. MARKET DYNAMICS

4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis

5. GLOBAL CYSTOSCOPE MARKET FORECAST BY TYPE

5.1. Rigid Cystoscope
5.2. Flexible Cystoscope

6. GLOBAL CYSTOSCOPE MARKET FORECAST BY APPLICATION

6.1. Urology
6.2. Gynaecology

7. GLOBAL CYSTOSCOPE MARKET FORECAST BY END-USER

7.1. Hospitals and Clinics
7.2. Ambulatory Surgical Centers

8. GLOBAL CYSTOSCOPE MARKET FORECAST BY GEOGRAPHY

8.1. North America
  8.1.1. The U.S
  8.1.2. Canada
  8.1.3. Mexico
  8.1.4. Others
8.2. South America
  8.2.1. Brazil
  8.2.2. Argentina
  8.2.3. Others
8.3. Europe
  8.3.1. U.K.
  8.3.2. France
  8.3.3. Germany
  8.3.4. Italy
  8.3.5. Others
8.4. Middle East and Africa
  8.4.1. UAE
  8.4.2. Saudi Arabia
  8.4.3. Israel
  8.4.4. Others
8.5. Asia Pacific
  8.5.1. China
  8.5.2. India
  8.5.3. Australia
  8.5.4. South Korea
  8.5.5. Others

9. COMPETITIVE INTELLIGENCE

9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals

10. COMPANY PROFILES

10.1. Stryker
  10.1.1. Overview
  10.1.2. Financials
  10.1.3. Product and Services
  10.1.4. Recent Development
10.2. PENTAX Medical
  10.2.1. Overview
  10.2.2. Financials
  10.2.3. Product and Services
  10.2.4. Recent Development
10.3. Olympus Corporation
  10.3.1. Overview
  10.3.2. Financials
  10.3.3. Product and Services
  10.3.4. Recent Development
10.4. Richard Wolf GmbH
  10.4.1. Overview
  10.4.2. Financials
  10.4.3. Product and Services
  10.4.4. Recent Development
10.5. Karl Storz
  10.5.1. Overview
  10.5.2. Financials
  10.5.3. Product and Services
  10.5.4. Recent Development
10.6. NeoScope Inc.
  10.6.1. Overview
  10.6.2. Financials
  10.6.3. Product and Services
  10.6.4. Recent Development
10.7. Coloplast Group
  10.7.1. Overview
  10.7.2. Financials
  10.7.3. Product and Services
  10.7.4. Recent Development
10.8. Cogentix Medical
  10.8.1. Overview
  10.8.2. Financials
  10.8.3. Product and Services
  10.8.4. Recent Development
10.9. Coloplast Group
  10.9.1. Overview
  10.9.2. Financials
  10.9.3. Product and Services
  10.9.4. Recent Development
10.10. Henke-Sass Wolf
  10.10.1. Overview
  10.10.2. Financials
  10.10.3. Product and Services
  10.10.4. Recent Development